Depletion of O6-methylguanine-DNA methyltransferase by O 6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines

Jun Murakami, You Jin Lee, Susumu Kokeguchi, Hidetsugu Tsujigiwa, Jun-Ichi Asaumi, Hitoshi Nagatsuka, Kazuhiro Fukui, Masahiro Kuroda, Noriaki Tanaka, Nagahide Matsubara

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

O6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme whose expression is controlled by its promoter methylation. A cell that expresses a low amount of MGMT is known to be more sensitive to the antiproliferative effects of alkylating agents. We have previously shown that the colorectal cancer patients treated with 5-fluorouracil (5-FU) as adjuvant chemotherapy had a better prognosis when the tumor revealed hypermethylation in its MGMT promoter. Therefore, we sought to investigate the relationship between the expression levels of MGMT and the antitumor effect of 5-FU in vitro by using two colon adenocarcinoma and four oral cancer cell lines with a variety of MGMT expression. We also investigated the effects of MGMT depletion by O 6-benzylguanine (O6-BG), a potent inhibitor of MGMT. The 5-FU treatment uniformly depleted protein and mRNA expression of MGMT in all cell lines examined. Cell lines expressing low levels of MGMT were sensitive to 5-FU. On the other hand, cells expressing high levels of MGMT were less sensitive to 5-FU. The 5-FU treatment exhibited a better antiproliferative effect on the cells expressing high levels of MGMT by the pretreatment of O 6-BG. Depletion of MGMT by O6-BG enhanced the antitumor effect of 5-FU. Assessment of the levels of MGMT expression in cancer cells and the control of its expression could contribute to the effective chemotherapy by 5-FU especially in patients who previously were considered as low-responsive individuals whose tumors have high levels of MGMT.

Original languageEnglish
Pages (from-to)1461-1467
Number of pages7
JournalOncology Reports
Volume17
Issue number6
Publication statusPublished - Jun 2007

Fingerprint

Mouth Neoplasms
Methyltransferases
Fluorouracil
Colonic Neoplasms
Cell Line
DNA
O(6)-benzylguanine
O-(6)-methylguanine
O(6)-Methylguanine-DNA Methyltransferase
DNA Repair Enzymes
Neoplasms
Alkylating Agents
Adjuvant Chemotherapy
Methylation
Colorectal Neoplasms
Colon
Adenocarcinoma

Keywords

  • 5-Fluorouracil
  • O -benzylguanine
  • O- methylguanine-DNA methyltransferase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Depletion of O6-methylguanine-DNA methyltransferase by O 6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines. / Murakami, Jun; Lee, You Jin; Kokeguchi, Susumu; Tsujigiwa, Hidetsugu; Asaumi, Jun-Ichi; Nagatsuka, Hitoshi; Fukui, Kazuhiro; Kuroda, Masahiro; Tanaka, Noriaki; Matsubara, Nagahide.

In: Oncology Reports, Vol. 17, No. 6, 06.2007, p. 1461-1467.

Research output: Contribution to journalArticle

@article{75b9cb31f0864448b90206e7a5ef8dac,
title = "Depletion of O6-methylguanine-DNA methyltransferase by O 6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines",
abstract = "O6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme whose expression is controlled by its promoter methylation. A cell that expresses a low amount of MGMT is known to be more sensitive to the antiproliferative effects of alkylating agents. We have previously shown that the colorectal cancer patients treated with 5-fluorouracil (5-FU) as adjuvant chemotherapy had a better prognosis when the tumor revealed hypermethylation in its MGMT promoter. Therefore, we sought to investigate the relationship between the expression levels of MGMT and the antitumor effect of 5-FU in vitro by using two colon adenocarcinoma and four oral cancer cell lines with a variety of MGMT expression. We also investigated the effects of MGMT depletion by O 6-benzylguanine (O6-BG), a potent inhibitor of MGMT. The 5-FU treatment uniformly depleted protein and mRNA expression of MGMT in all cell lines examined. Cell lines expressing low levels of MGMT were sensitive to 5-FU. On the other hand, cells expressing high levels of MGMT were less sensitive to 5-FU. The 5-FU treatment exhibited a better antiproliferative effect on the cells expressing high levels of MGMT by the pretreatment of O 6-BG. Depletion of MGMT by O6-BG enhanced the antitumor effect of 5-FU. Assessment of the levels of MGMT expression in cancer cells and the control of its expression could contribute to the effective chemotherapy by 5-FU especially in patients who previously were considered as low-responsive individuals whose tumors have high levels of MGMT.",
keywords = "5-Fluorouracil, O -benzylguanine, O- methylguanine-DNA methyltransferase",
author = "Jun Murakami and Lee, {You Jin} and Susumu Kokeguchi and Hidetsugu Tsujigiwa and Jun-Ichi Asaumi and Hitoshi Nagatsuka and Kazuhiro Fukui and Masahiro Kuroda and Noriaki Tanaka and Nagahide Matsubara",
year = "2007",
month = "6",
language = "English",
volume = "17",
pages = "1461--1467",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Depletion of O6-methylguanine-DNA methyltransferase by O 6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines

AU - Murakami, Jun

AU - Lee, You Jin

AU - Kokeguchi, Susumu

AU - Tsujigiwa, Hidetsugu

AU - Asaumi, Jun-Ichi

AU - Nagatsuka, Hitoshi

AU - Fukui, Kazuhiro

AU - Kuroda, Masahiro

AU - Tanaka, Noriaki

AU - Matsubara, Nagahide

PY - 2007/6

Y1 - 2007/6

N2 - O6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme whose expression is controlled by its promoter methylation. A cell that expresses a low amount of MGMT is known to be more sensitive to the antiproliferative effects of alkylating agents. We have previously shown that the colorectal cancer patients treated with 5-fluorouracil (5-FU) as adjuvant chemotherapy had a better prognosis when the tumor revealed hypermethylation in its MGMT promoter. Therefore, we sought to investigate the relationship between the expression levels of MGMT and the antitumor effect of 5-FU in vitro by using two colon adenocarcinoma and four oral cancer cell lines with a variety of MGMT expression. We also investigated the effects of MGMT depletion by O 6-benzylguanine (O6-BG), a potent inhibitor of MGMT. The 5-FU treatment uniformly depleted protein and mRNA expression of MGMT in all cell lines examined. Cell lines expressing low levels of MGMT were sensitive to 5-FU. On the other hand, cells expressing high levels of MGMT were less sensitive to 5-FU. The 5-FU treatment exhibited a better antiproliferative effect on the cells expressing high levels of MGMT by the pretreatment of O 6-BG. Depletion of MGMT by O6-BG enhanced the antitumor effect of 5-FU. Assessment of the levels of MGMT expression in cancer cells and the control of its expression could contribute to the effective chemotherapy by 5-FU especially in patients who previously were considered as low-responsive individuals whose tumors have high levels of MGMT.

AB - O6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme whose expression is controlled by its promoter methylation. A cell that expresses a low amount of MGMT is known to be more sensitive to the antiproliferative effects of alkylating agents. We have previously shown that the colorectal cancer patients treated with 5-fluorouracil (5-FU) as adjuvant chemotherapy had a better prognosis when the tumor revealed hypermethylation in its MGMT promoter. Therefore, we sought to investigate the relationship between the expression levels of MGMT and the antitumor effect of 5-FU in vitro by using two colon adenocarcinoma and four oral cancer cell lines with a variety of MGMT expression. We also investigated the effects of MGMT depletion by O 6-benzylguanine (O6-BG), a potent inhibitor of MGMT. The 5-FU treatment uniformly depleted protein and mRNA expression of MGMT in all cell lines examined. Cell lines expressing low levels of MGMT were sensitive to 5-FU. On the other hand, cells expressing high levels of MGMT were less sensitive to 5-FU. The 5-FU treatment exhibited a better antiproliferative effect on the cells expressing high levels of MGMT by the pretreatment of O 6-BG. Depletion of MGMT by O6-BG enhanced the antitumor effect of 5-FU. Assessment of the levels of MGMT expression in cancer cells and the control of its expression could contribute to the effective chemotherapy by 5-FU especially in patients who previously were considered as low-responsive individuals whose tumors have high levels of MGMT.

KW - 5-Fluorouracil

KW - O -benzylguanine

KW - O- methylguanine-DNA methyltransferase

UR - http://www.scopus.com/inward/record.url?scp=34548014313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548014313&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 1461

EP - 1467

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 6

ER -